(LCCN) Lyxor MSCI China - Acc - Ratings and Ratios

The Lyxor MSCI China UCITS ETF - Acc CHF is an exchange-traded fund that tracks the Morningstar China TME NR USD index, providing investors with exposure to the Chinese equity market. As a Switzerland-domiciled ETF, it offers a convenient way to tap into the growth potential of Chinas economy.

From a technical analysis perspective, the ETFs price action indicates a bullish trend, with the short-term Simple Moving Average (SMA20) at 16.55 and the long-term SMA200 at 15.88, suggesting an upward momentum. The Average True Range (ATR) of 0.20, equivalent to 1.21%, indicates a moderate level of volatility. Given the current price of 16.72, we can expect the ETF to continue its upward trajectory, with potential resistance at the 52-week high of 19.00.

Fundamentally, the ETFs Assets Under Management (AUM) stand at 686.14M CHF, indicating a moderate level of investor interest. As the Chinese economy continues to grow, driven by government initiatives and increasing consumer spending, the ETF is well-positioned to benefit from this trend. With the Morningstar China TME NR USD index as its underlying benchmark, the ETF provides diversified exposure to Chinas equity market, including large-cap and mid-cap stocks.

Forecasting the ETFs future performance, we can combine technical and fundamental insights. Based on the bullish trend indicated by the SMA20 and SMA50, and the moderate AUM, we expect the ETFs price to reach 18.50 in the next 6-12 months, representing a potential upside of 10.6% from current levels. However, investors should be cautious of potential volatility, as indicated by the ATR, and monitor the ETFs performance closely.